DUSP6 deletion protects mice and reduces disease severity in autoimmune arthritis

Teresina Laragione; Carolyn Harris; Natasha Rice; Percio S Gulko

doi:10.1016/j.isci.2024.110158

DUSP6 deletion protects mice and reduces disease severity in autoimmune arthritis

iScience. 2024 May 31;27(6):110158. doi: 10.1016/j.isci.2024.110158. eCollection 2024 Jun 21.

Authors

Teresina Laragione¹, Carolyn Harris¹, Natasha Rice¹, Percio S Gulko¹

Affiliation

¹ Division of Rheumatology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Abstract

Receptor tyrosine kinases (RTKs) have an important role in arthritis severity and in models of rheumatoid arthritis (RA), but their regulation is not fully understood. The dual specificity phosphatase 6 (DUSP6) has been implicated in the regulation of RTK signaling, but never in the context of arthritis and autoimmunity. We used the KRN serum-induced arthritis (KSIA) model of RA and showed that DUSP6^-/- mice were protected and had a 50% lower maximum arthritis score (p = 0.006) and reduced joint damage than C57BL/6 DUSP6+/+ controls. Serum levels of interleukin (IL) 10 were significantly increased (>2-fold), and IL6 decreased in DUSP6^-/- mice. DUSP6^-/- mice had increased numbers of IL10+ cells including Tr1 regulatory cells (p < 0.01). Introduction of the IL10^-/- into DUSP6^-/- (double knockout [KO]) reversed the DUSP6^-/- protection. In conclusion, this study reports a pro-arthritic role for DUSP6. This discovery has the potential to generate a previously unknown target for therapies for RA and inflammatory diseases.

Keywords: Biological sciences; Health sciences; Immunology; Molecular biology; Physiology.

Grants and funding

R01 AR073165/AR/NIAMS NIH HHS/United States